OxSonics Therapeutics
PrivateLast Round
Series B
Extension
Jul 1, 2020
Total Funding Raised
$25.48M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
OxSonics Therapeutics operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a Series B Extension round in July 2020.
OxSonics Therapeutics is a clinical-stage medtech company that develops ultrasound-based drug delivery platforms to enhance the efficacy of oncology treatments for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OxSonics Therapeutics Comparables
Compare OxSonics Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IMGT Co., Ltd. | 83% | |
| Carthera | 82% | |
| Cordance Medical | 77% |
For institutional investors. Book with your work email.
OxSonics Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jul 1, 2020 | ||||
| Seed | Jan 1, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OxSonics Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Perivoli Innovations | Series B Extension |
| MMK Capital | Series B Extension |
| Oxford University Innovation | Series B, Seed |
| Oxford Technology and Innovations EIS Fund | Series B Extension |
| Longwall Venture Partners | Series B Extension, Series B, Seed |
| National Institute for Health and Care Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 1413% MoM.
- Jun 2, 2025
Monthly visitors increased 80% MoM.
For institutional investors. Book with your work email.
OxSonics Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OxSonics Therapeutics's valuation, stock price, and market status.
Is OxSonics Therapeutics a public or private company?
OxSonics Therapeutics is a private company.
What is the current stock price of OxSonics Therapeutics?
OxSonics Therapeutics is a private company, so its shares have no public market price. Caplight tracks OxSonics Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OxSonics Therapeutics worth (valuation)?
Valuation information for OxSonics Therapeutics is not publicly available.
Can I buy OxSonics Therapeutics stock?
OxSonics Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OxSonics Therapeutics's last funding round?
OxSonics Therapeutics's most recent funding round was Series B Extension on July 1, 2020.
Who are the main investors in OxSonics Therapeutics?
Key investors in OxSonics Therapeutics include Perivoli Innovations, MMK Capital, Oxford University Innovation, Oxford Technology and Innovations EIS Fund, Longwall Venture Partners.
Will OxSonics Therapeutics IPO soon?
No public IPO plans have been announced for OxSonics Therapeutics.
How can I track OxSonics Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in OxSonics Therapeutics's shares on secondary markets.